BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29776220)

  • 1. Delivering on the promise of personalized healthcare.
    March R
    Per Med; 2010 May; 7(3):327-337. PubMed ID: 29776220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
    Akhmetov I; Bubnov RV
    EPMA J; 2017 Dec; 8(1):5-15. PubMed ID: 28228864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics.
    Batrla R; Jordan BW
    Ann N Y Acad Sci; 2015 Jun; 1346(1):71-80. PubMed ID: 25866164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a framework for personalized healthcare: lessons learned from the field of rare diseases.
    Tambuyzer E
    Per Med; 2010 Sep; 7(5):569-586. PubMed ID: 29776250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized health care as a pathway for the adoption of genomic medicine.
    Burnette R; Simmons LA; Snyderman R
    J Pers Med; 2012 Nov; 2(4):232-40. PubMed ID: 25562362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and health economic challenges of personalized medicine].
    Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoarthritis--a case for personalized health care?
    Karsdal MA; Christiansen C; Ladel C; Henriksen K; Kraus VB; Bay-Jensen AC
    Osteoarthritis Cartilage; 2014 Jan; 22(1):7-16. PubMed ID: 24216058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the codevelopment of companion diagnostics.
    Moore MW; Babu D; Cotter PD
    Per Med; 2012 Jul; 9(5):485-496. PubMed ID: 29768776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.
    Simmons LA; Dinan MA; Robinson TJ; Snyderman R
    Per Med; 2012 Jan; 9(1):85-91. PubMed ID: 29783292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An industry statistician's perspective on PHC drug development.
    Fridlyand J; Yeh RF; Mackey H; Bengtsson T; Delmar P; Spaniolo G; Lieberman G
    Contemp Clin Trials; 2013 Nov; 36(2):624-35. PubMed ID: 23648396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating complexity: partnerships in personalized medicine.
    Pothier K; Gustavsen G
    Per Med; 2013 Jun; 10(4):387-396. PubMed ID: 29783418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
    Verma M
    Per Med; 2014 Nov; 11(8):761-771. PubMed ID: 29764045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
    Frueh FW
    Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US FDA and personalized medicine: in vitro diagnostic regulatory perspective.
    Težak Ž; Kondratovich MV; Mansfield E
    Per Med; 2010 Sep; 7(5):517-530. PubMed ID: 29776248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where Personalized Medicine, Patient Engagement, and Primary Care Collide.
    Bell M
    S D Med; 2017 Spec; Spec No():34-36. PubMed ID: 28817860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.
    Barsanti-Innes B; Hey SP; Kimmelman J
    Oncologist; 2017 Jan; 22(1):89-96. PubMed ID: 28126916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine: progress and promise.
    Chan IS; Ginsburg GS
    Annu Rev Genomics Hum Genet; 2011; 12():217-44. PubMed ID: 21721939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.